Skip to main content
. Author manuscript; available in PMC: 2019 Jul 15.
Published in final edited form as: Clin Cancer Res. 2018 Apr 4;24(14):3299–3308. doi: 10.1158/1078-0432.CCR-17-3008

Figure 5. HDI/HDD alteration frequencies in 109 melanoma patients treated with ipilimumab.

Figure 5

Oncoprint plot showing the deletion landscape of interferon genes, defensin genes, CDKN2A and PTEN in 109 metastatic melanoma patients. Patients were divided into 3 groups including non-responder (N = 72), responder (N = 27) and long-term survival (N = 10), according the response outcomes to ipilimumab. HDI, homozygous deletion of type-I interferons; HDD, homozygous deletion of defensin.